Leap Therapeutics (LPTX) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.49
-0.43
-0.36
-0.29

Details

Expected EPS
-0.29
Actual EPS
-0.4
Surprise EPS
-0.11
Surprise Percent
+37.93%

Description

Leap Therapeutics (LPTX) has reported earnings of -0.4 per share for Q3 2025.

0 Comments

Share your thoughts